Beigene (ONC) Competitors $219.67 -3.83 (-1.71%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends ONC vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Beigene stock or one of its competitors? The main competitors of Beigene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Beigene vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Aravive Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Beigene (NASDAQ:ONC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk, media sentiment and community ranking. Which has preferable valuation and earnings, ATNFW or ONC? 180 Life Sciences has higher earnings, but lower revenue than Beigene. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ABeigene$2.46B8.73-$881.71M-$8.24-26.66 Does the MarketBeat Community prefer ATNFW or ONC? 180 Life Sciences and Beigene both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ABeigeneN/AN/A Do insiders and institutionals believe in ATNFW or ONC? 48.6% of Beigene shares are held by institutional investors. 7.4% of Beigene shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is ATNFW or ONC more profitable? 180 Life Sciences has a net margin of 0.00% compared to Beigene's net margin of -25.94%. 180 Life Sciences' return on equity of 0.00% beat Beigene's return on equity.Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Beigene -25.94%-25.12%-14.95% Does the media refer more to ATNFW or ONC? In the previous week, Beigene had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Beigene and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.40 beat Beigene's score of 1.27 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 180 Life Sciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beigene 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Summary180 Life Sciences and Beigene tied by winning 4 of the 8 factors compared between the two stocks. Get Beigene News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONC vs. The Competition Export to ExcelMetricBeigenePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.47B$6.92B$5.68B$9.04BDividend YieldN/A2.91%5.30%4.00%P/E Ratio-26.669.6589.7819.46Price / Sales8.73323.501,038.1274.17Price / CashN/A75.4646.0638.79Price / Book5.925.635.134.78Net Income-$881.71M$123.93M$113.50M$222.19M7 Day PerformanceN/A-0.21%0.42%1.42%1 Month PerformanceN/A-0.44%3.65%2.91%1 Year PerformanceN/A5.40%22.50%20.50% Beigene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCBeigeneN/A$219.67-1.7%N/AN/A$21.47B$2.46B-26.6610,600Analyst RevisionNews CoveragePositive NewsATNFW180 Life SciencesN/A$0.01+9.1%N/A+106.9%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.04+14.3%N/A+24.6%$0.00N/A0.002Gap DownHigh Trading VolumeAIMDWAinosN/A$0.15+51.5%N/A+207.8%$0.00$40,633.000.0040Positive NewsALVOWAlvotechN/A$2.40+9.1%N/A-44.6%$0.00$391.87M0.004Positive NewsARAVAraviveN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/AN/A$0.00N/A0.004BFRIWBiofronteraN/A$0.06-6.3%N/A+448.5%$0.00$35.36M0.0070High Trading VolumeBTMDWbioteN/A$0.50flatN/AN/A$0.00$193.06M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.11-9.2%N/A-91.9%$0.00N/A0.008 Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ARAV Alternatives ACABW Alternatives BFRIW Alternatives BTMDW Alternatives BCTXW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ONC) was last updated on 2/10/2025 by MarketBeat.com Staff From Our PartnersA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored5-Second Trump Clip will Give You ChillsPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredElon’s ‘Agents’ StrikeHe might be the richest man on the planet – but Elon Musk just landed himself a new job... In a move that c...Altimetry | SponsoredBill O’Reilly: “the best-prepared president in history.”"We're going to bring back the American Dream... bigger, better, bolder, richer, safer, and stronger than ever...The Oxford Club | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beigene, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beigene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
